Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Insomnia01:27

Insomnia

119
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
119
Management of Insomnia01:19

Management of Insomnia

313
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
313
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

198
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
198
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

1.5K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.5K
Narcolepsy01:07

Narcolepsy

180
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
180
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

282
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
282

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The association between slow wave activity and memory improvement following cognitive-behavioral therapy for insomnia in older adults: A secondary analysis of a randomized clinical trial​.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same author

Risks Associated With Benzodiazepine Long-Term Use in Chronic Insomnia: A Systematic Review and (Network) Meta-Analysis.

Journal of sleep research·2026
Same author

Cognitive status moderates long-term benefits of non-pharmacological insomnia therapy in older adults: A secondary analysis of a randomized clinical trial.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Targeting hyperarousal to improve sleep: A network intervention analysis of a digital intervention for insomnia.

Behaviour research and therapy·2026
Same author

Cognitive and emotional correlates of sleep in the peripartum period: a systematic review.

Behaviour research and therapy·2026
Same author

Longitudinal gray matter volume changes associated with obstructive sleep apnea are age-dependent.

American journal of respiratory and critical care medicine·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Aug 28, 2025

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.2K

不眠症

Michael L Perlis1, Donn Posner2, Dieter Riemann3

  • 1Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.

Lancet (London, England)
|September 17, 2022
PubMed
まとめ
この要約は機械生成です。

不眠症に対する認知行動療法 (CBT-I) は,持続的な長期的な効果を提供する,推奨される第一線治療である. CBT-Iと薬を併用すると 初期反応が早まるかもしれませんが 長期的な効果は低下する可能性があります

さらに関連する動画

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

5.4K
Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice
10:56

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice

Published on: August 2, 2017

10.1K

関連する実験動画

Last Updated: Aug 28, 2025

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.2K
A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

5.4K
Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice
10:56

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice

Published on: August 2, 2017

10.1K

科学分野:

  • 医学について
  • 精神科
  • 睡眠医学

背景:

  • 失眠症は 医療従事者の50%まで罹患します
  • 不眠症は他の医学的および精神的健康障害の危険因子です.
  • アメリカン・カレッジ・オブ・フィジシャンスでは 不眠症の治療を推奨しています

研究 の 目的:

  • 不眠症治療の効果とリスク・利益のプロフィールを見直す.
  • 不眠症に対する認知行動療法 (CBT-I) と薬理学的介入を比較する.
  • CBT-Iと薬の併用による治療結果の影響を評価する.

主な方法:

  • 現在の不眠症治療ガイドラインと研究の文献レビュー.
  • 不眠症に対するCBT-Iと薬学的治療の比較分析
  • CBT-Iと薬物治療の組み合わせに関する研究の検討

主要な成果:

  • CBT-Iは不眠症の第一線治療として推奨されています.
  • CBT-Iと薬理学的治療の両方が同様の急性効果を示しています.
  • CBT-Iは 治療後の長期にわたる効果を示します 薬とは違います
  • 併用治療は反応を早めるが,長期的な耐久性を低下させる可能性がある.

結論:

  • CBT-Iは 持続的な効果があるため 不眠症の治療に最適です
  • 薬理学的治療には有効性やリスク・利益に関する明確なコンセンサスが欠けている.
  • 併用療法では,迅速な反応と長期的な耐久性との間のトレードオフが可能です.